Globe Life (NYSE:GL) Releases FY 2027 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2027 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 16.100-17.100 for the period, compared to the consensus earnings per share estimate of 16.510. Globe Life also updated its FY 2026 guidance to 15.350-15.650 EPS.

Globe Life Stock Down 8.1%

Shares of Globe Life stock traded down $13.69 during trading on Friday, hitting $154.72. 661,370 shares of the stock traded hands, compared to its average volume of 543,348. The stock has a market cap of $11.89 billion, a P/E ratio of 10.24 and a beta of 0.44. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life has a twelve month low of $127.85 and a twelve month high of $191.55. The company has a fifty day moving average price of $170.48 and a two-hundred day moving average price of $167.25.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, October 21st. The company reported $4.84 EPS for the quarter, missing the consensus estimate of $4.90 by ($0.06). Globe Life had a net margin of 18.89% and a return on equity of 19.95%. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm posted $4.81 EPS. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. Equities research analysts predict that Globe Life will post 15.70 EPS for the current fiscal year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be paid a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. Globe Life’s payout ratio is 8.76%.

Globe Life announced that its board has approved a stock buyback program on Monday, August 10th that allows the company to repurchase $2.50 billion in shares. This repurchase authorization allows the company to repurchase up to 17.7% of its shares through open market purchases. Share repurchase programs are typically an indication that the company’s management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on GL shares. Jefferies Financial Group increased their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. Piper Sandler downgraded shares of Globe Life from an “overweight” rating to a “neutral” rating and set a $165.00 price target on the stock. in a report on Friday. Morgan Stanley reduced their price objective on shares of Globe Life from $208.00 to $197.00 and set an “overweight” rating for the company in a research note on Monday, October 5th. Wells Fargo & Company upped their price objective on shares of Globe Life from $190.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 12th. Finally, JPMorgan Chase & Co. increased their target price on shares of Globe Life from $193.00 to $195.00 and gave the stock an “overweight” rating in a research report on Thursday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $182.60.

Insider Activity

In other news, CFO Thomas Kalmbach sold 21,000 shares of the business’s stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer directly owned 50,568 shares in the company, valued at approximately $9,105,274.08. The trade was a 29.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO James Darden sold 50,000 shares of the company’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. This represents a 46.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 143,650 shares of company stock valued at $25,793,717 over the last three months. Corporate insiders own 2.11% of the company’s stock.

Key Globe Life News

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: TD Cowen maintained a Buy rating and lowered its price target from $225 to $215, still implying substantial upside from current levels. TD Cowen Globe Life price target update
• Positive Sentiment: Globe Life projected 2027 adjusted EPS of $16.10 to $17.10, with the midpoint modestly above the current consensus estimate, and targeted $850 million to $950 million in parent excess cash flow. Globe Life 2027 earnings and cash flow outlook
• Positive Sentiment: Third-quarter revenue rose 5.5% year over year to approximately $1.60 billion, exceeding analyst expectations, while operating EPS increased slightly from $4.81 to $4.84. Globe Life third-quarter 2026 results
• Neutral Sentiment: For 2027, the EPS guidance range broadly brackets consensus, suggesting expectations remain intact but with a relatively wide outlook range.
• Negative Sentiment: Third-quarter operating EPS of $4.84 missed the approximately $4.90 consensus estimate. Weaker underwriting income and higher expenses offset gains from premiums and investment income. Globe Life third-quarter earnings miss
• Negative Sentiment: Globe Life reduced its 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Losses tied to Evry Health were cited among the factors behind the guidance cut. Evry Health losses and Globe Life guidance
• Negative Sentiment: Piper Sandler downgraded the stock following the quarterly announcement, reinforcing concerns about underwriting performance and near-term earnings. Piper Sandler Globe Life downgrade

Globe Life Company Profile

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.